Biomerica, Inc. announced the appointment of Gary Huff to its Strategic Advisory Board (SAB). Mr. Huff, former CEO of Diagnostics at Laboratory Corporation of America Holdings, ?LabCorp?, brings extensive expertise to collaborate with Jack Kenny, Chairman of Biomerica, and Zack Irani, CEO of Biomerica, in driving expansion of the inFoods® IBS product. Most recently, Mr. Huff served as the CEO of LabCorp Diagnostics, overseeing one of the world?s largest diagnostics clinical laboratories, boasting $7 billion in annual revenues, over 2,000 locations, and a workforce of 36,000 employees.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.58 USD | 0.00% | +4.28% | -53.60% |
Annual profits - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-53.60% | 9.76M | |
-5.17% | 184B | |
-0.18% | 107B | |
-4.04% | 67.9B | |
-5.55% | 46.49B | |
+12.06% | 45.81B | |
+7.40% | 42.55B | |
+20.33% | 30.78B | |
+14.24% | 26.11B | |
-3.89% | 23.9B |
- Stock Market
- Equities
- BMRA Stock
- News Biomerica, Inc.
- Biomerica, Inc. Announces the Appointment of Gary Huff to Its Strategic Advisory Board